23 May 2013
Keywords: cytrx, hit, gw, decision, drop, rheothrx, announced
Article | 30 October 1995
CytRx has announced that Glaxo Wellcome, its corporate partner for the
development of RheothRx (poloxamer 188) injection, a non-ionic block
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 October 1995
© 2013 thepharmaletter.com